Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 15.31M P/E - EPS this Y - Ern Qtrly Grth -
Income -21.68M Forward P/E -0.29 EPS next Y - 50D Avg Chg 19.00%
Sales 68k PEG - EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 1.97 EPS next 5Y 20.00% 52W High Chg -77.00%
Recommedations 3.00 Quick Ratio 1.22 Shares Outstanding 5.41M 52W Low Chg 49.00%
Insider Own 39.31% ROA -36.19% Shares Float 2.95M Beta 8.16
Inst Own 16.19% ROE -302.20% Shares Shorted/Prior 42.43K/37.78K Price 2.83
Gross Margin -247.06% Profit Margin - Avg. Volume 27,880 Target Price -
Oper. Margin -33,911.77% Earnings Date May 6 Volume 4,406 Change 2.89%
About Eterna Therapeutics Inc.

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Eterna Therapeutics Inc. News
02/20/24 Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
01/03/24 Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
12/21/23 Eterna Therapeutics Appoints Sanjeev Luther as President and CEO
12/20/23 Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
12/14/23 Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
11/02/23 Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors
11/01/23 Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
09/08/23 Insider Stock Buying Reaches US$2.7m On Eterna Therapeutics
09/06/23 Eterna Therapeutics Teams with Lineage Cell on Transplant Therapies
09/06/23 EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
09/06/23 Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
09/05/23 Eterna Therapeutics Appoints Dorothy Clarke to Board of Directors
09/05/23 Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
07/18/23 Eterna Therapeutics Announces $8.7M Private Placement Transaction
07/18/23 Eterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing
07/11/23 Eterna Therapeutics Appoints Industry Veterans Binder, Wagner to Board of Directors
07/11/23 Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
10:18 AM Eterna Therapeutics Appoints Megan Yung as CSO, General Counsel
07:30 AM Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
05/17/23 Eterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
ERNA Chatroom

User Image Ridiculous78 Posted - 1 hour ago

$ERNA

User Image Ridiculous78 Posted - 2 hours ago

$ERNA

User Image Ridiculous78 Posted - 2 hours ago

$ERNA 3/3

User Image Ridiculous78 Posted - 2 hours ago

$ERNA 2/3

User Image Ridiculous78 Posted - 2 hours ago

$ERNA Get your wallets ready if this goes back to the 1.4s

User Image Ridiculous78 Posted - 2 weeks ago

@Giggtitties @LabPsycho @Telgar Ive followed this for about a year now. To be completely honest, I think the only reason it had a movement like it did was because of CRBP and AMAM shaking the ADC space. I saw this coming when AMAM got acquired despite being mostly Phase 1, and all the ADC stocks began to heat up as people were learning more about what ADCs actually are/do. I like Hamdy, something that never sat right with me was that years later it came out that a lot of the preclinical data at Acerta (mouse models) had been over exaggerated/spoofed. Not saying that is the case with VINC— but it’s notable that when I first found this stock, the only thing going for their ADCs was “impressive” results in mouse/chimp models. Now we’ve gotten clinical results and they’re pretty lackluster. Almost my entire bio portfolio is now in cell engineering, $ERNA to be specific. It is a licensing company for a private lab called Factor Bio. Lots of private interest, little retail attention.

User Image Russell007xx Posted - 3 weeks ago

$ERNA we need 800% up from here

User Image Ridiculous78 Posted - 03/29/24

$ERNA Past 3 months, 10K update: Insider holdings increased 3% to 44% total - Sanjeev Luther awarded 1.8m shares at 1.80/s Institutional holdings increased 9% to 19% - Lake Street opens position for 525k shares Private placement given roughly 10 million warrants -weighted average now 2.05 exercise price Lincoln Park agreement still active to buy shares any time valued up to 10 million, dispersed at digression of Eterna - .03M sold so far

User Image Russell007xx Posted - 03/28/24

$AVTX $ERNA next

User Image Russell007xx Posted - 03/28/24

$AVTX buy $ERNA and thank me Later.

User Image Russell007xx Posted - 03/28/24

$AVTX $ERNA i have a feeling that this could go like Avtx

User Image Russell007xx Posted - 03/28/24

$ERNA next like $AVTX

User Image ShamUS1 Posted - 03/26/24

$ERNA Where did the PM gains go🤮

User Image Russell007xx Posted - 03/26/24

$ERNA i need 20 dollars by mid april

User Image Ridiculous78 Posted - 1 month ago

Trading from 🇧🇿 for the next few weeks.. added $ALPN to the LT bio watchlist today $CJJD , $LGCL , $RGC China based with good set up added to watchlist $ERNA adding daily

User Image alex1379 Posted - 1 month ago

$ERNA 23 cents up and $8 to go to breakeven and that’s after increasing position 10x at $1.80. Good old days of 2021 🤣

User Image Stocks4thought Posted - 1 month ago

$ERNA What do you buy the what's behind the curtain- no pipeline listing? https://eternatx.com/pipeline/

User Image RealErnFranklin Posted - 1 month ago

$SVMH billy! 🔥🔥 slappa $ERNA sneaking up here. Hadnt seen that movement. One big pump to 3.5 now $cjjd should have its day eow

User Image Ridiculous78 Posted - 1 month ago

$CRBP 3–>36 $OCEA .65–> 7 $ERNA 1.80 —-> ?

User Image Russell007xx Posted - 1 month ago

$ERNA can we see 35 that’s my average 😂

User Image WolfofYYC Posted - 1 month ago

$ERNA PEGY is going to run next!!!

User Image Duce2000 Posted - 1 month ago

$ERNA It’s our time (again?)

User Image Ridiculous78 Posted - 02/29/24

$ERNA Synthetic cell delivery system that overcomes current issues with delivering mRNA to sensitive organs (lungs, brain), and through serum. Synthetic mRNA encoded inside cell is masked using gene-editing stealth technology to prevent GvHD and toxicity. $LCTX $CRSP $MRNA $ALLO

User Image snosrap Posted - 02/29/24

@Gromit00 @Ablidy @WaveyMaybeDavey @MajorBlockbuster we have an iron in this fire with $ERNA but yes ages away. Amazing how unknown or not believed we are. Maybe just the hesc side keeps peeps away. And the lack of cash, or the appearance of. I would have thought the tiny offering would have gotten noticed, in that we didnt do $200m offering.

User Image Russell007xx Posted - 02/28/24

$ERNA when can we see 80 again? After we die😡

User Image Ridiculous78 Posted - 02/26/24

$CRBP at $3 $OCEA at $1 & $ERNA at current . Pre-clin picks from 11/15/23. All in on ERNA now. It’s been a wild 3 months! Majority of my portfolio in ERNA & buying more weekly.

User Image Ridiculous78 Posted - 2 months ago

@Stocktradamu5 One of my biggest holdings at around $9, admittedly I took profit at $14 today. Will be back in once it goes under $10 again. I was early to $IMGN and $AMAM before the buyouts. $GLSI and $ERNA are my next two best bets for buyout candidate. $GLSI a better chance near term because it’s late Phase 3 with incredible results over SoC for BC reoccurrence prevention.

User Image Ridiculous78 Posted - 2 months ago

$ERNA Factor Bio, parent company, announced January 9th US government DoD contract https://factor.bio/news/factor-bioscience-announces-u-s-department-of-defense-grant-to-develop-gene-edited-cell-therapies/

User Image snosrap Posted - 2 months ago

@MajorBlockbuster @geroscience we slso compete (broadly) with our $ERNA partnership with editing "Alongside its unmodified cell therapy candidates, Neurona is developing genetically modified, or gene-edited, cell types for targeted delivery of therapeutic factors to the central nervous system (CNS)." And OPC1 human oligodendrocyte glial cell therapy. They are not focused on spinal cord though. Looks like hESC and IPSC, thats important. Great for these Px. Future bright here, more confirmation.

User Image Ridiculous78 Posted - 2 months ago

$FATE Very similar to $ERNA. One has had a nice run up from a dollar, one hasn’t. One has a 100M float, one has a 3M float that is 58% insider owned. -Both doing iPSC derived macrophage/NK cell mRNA research for cancer and neurological indications. -Both own their means of manufacturing through subsidiary companies. -Both have a rich patent portfolio. ERNA is extremely undervalued.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cherington Charles Director Director Dec 02 Buy 3.28 261,756 858,560 556,465 12/06/22
Singer Nicholas Jason Director Director Dec 02 Buy 3.28 283,286 929,178 266,214 12/06/22
DENNY GEORGE P III 10% Owner 10% Owner Aug 20 Sell 16.06 75,000 1,204,500 4,775,117 08/20/21
DENNY GEORGE P III 10% Owner 10% Owner Aug 20 Buy 13.48 3 40 3 08/20/21